Nimesulide for rapid pain relief

Non-steroidal anti-inflammatory pain relief drug Nimesulide is prescribed for the treatment of acute pain, Primary dysmennorhea and also to treat degenerative joint disease.

The drug is developed by Helsinn Healthcare. Medicines containing Nimesulide are on the market since 1985 and are authorised in a number of Member States.

Nimesulide also improves the skin tone and to increase in energy levels. Food, gender and advanced age have negligible effects on Nimesulide pharmacokinetics.

Its multifactorial mode of action gives it a unique and broad action on inflammatory processes.

Clinical studies have been carried out in a wide variety of acute inflammatory and painful conditions with the aim of evaluating the analgesic activity of nimesulide in comparison to placebo and to some of the most common NSAIDs.

In these studies, the efficacy of nimesulide was consistently superior to placebo with a particularly fast onset of the analgesic action.

This rapid onset of analgesic action shows meaningful reductions in pain and inflammation observed within 15 minutes from drug intake.

Unlike, other NSAIDs, the chemical structure of nimesulide does not contain a carboxylic group but a sulfonanilide moiety as the acidic group.

As with all drugs, therapy appropriateness when using nimesulide is of outmost importance to safeguard patient’s health and guarantee the product’s therapeutic value.

Prescribe pain killer drug

The most prescribed anti-inflamatory drug Nimesulide was first developed by Helsinn Healthcare and is marketed world-wide.

NImesulide is available in the form of tablets (100 mg), granules for oral suspension (100 mg), suppositories (200 mg) and gel (3%).

The anti-inflammatory drug mechanism of Nimesulide should only be prescribed as second line treatment. It provides the fast onset of the analgesic action.

The rapid onset of the analgesic action is crucial for the patients with acute pain and also in case of treatment with systemic NSAIDs

The harmonized indications in the EU are acute pain, primary dysmenorrhoea. The dosage of Nimesulide ought to be used is 100 mg twice daily, the duration prescribed is 15 days to minimize the risk of hepatotoxicity.

The drug must be used under supervision by a licensed physician in accordance with the approved indications. Prescription of the Nimesulide must be based on assessment of the patients’ characteristics and needs. Nimesulide is contraindicated in children below 12 years and in patients suffering from liver problems.

Nimesulide pain killer drug

A unique Non-steroidal anti inflammatory drug Nimesulide was developed by Helsinn Healthcare and is marketed world-wide around 50 countries. It has proven benefits in the treatment of Acute (short term) pain, Painful osteoarthritis (Swelling in the joints) and Primary dysmennorhea ( Period Pains).

Nimesulide is a prescription anti-inflammatory drug with significant analgesic propertiesand antipyretic properties. It has superior gastrointestinal safety as compared to other NSAIDs.

Indications:

• Pain relief
• Rheumatoid arthritis
• Osteoarthritis
• Low back pain
• Post operative pain management
• Gynecological surgery: Hysterectomy,
• Dental pain

Nimesulide drug must be prescribed by a physician and doctor and is usually recommended for the age higher than 12 years.

Nimesulide is available with distinctive brands like Sulide, Nimalox, Nimesil, Nimulid, Nicip, Nimcap, Nise, Sulidene and Zolan.

Nimesulide tablet for pain killer

Nimesuilde is a pain killer NSAIDs drug is the best prescribed drug for treatment of acute pain, Primary dysmennorhea and also to treat degenerative joint disease.
Nimesulide drug was launched in Italy for the first time as Aulin and Mesulid in 1985 and is presentlyavailable in more than 50 countries worldwide with different trademarks.
Its multifactorial mode of action gives it a unique and broad action on inflammatory processes.
It has superior gastrointestinal safety as compared to other NSAIDs. It is an analgesic and antipyretic in action, other than its anti inflammatory action. 
Unlike, other NSAIDs, the chemical structure of nimesulide does not contain a carboxylic group but a sulfonanilide moiety as the acidic group. 
Apart from tablet the drug- Nimesulide is also available in various forms such as in the form of Gell, powder, and suppositories. It’s also available in various brand names of Sulide, Nimalox, Nimesil, Nimulid, Nicip, Nimcap, Nise, Sulidene and Zolan e.t.c.The Nimulid Transgel a brand from Nimesulide Transdermal Gel is indicated for post-traumatic inflammation, acute musculoskeletal disorders including sprains, strains, tendinitis, tenosynovitis, low back pain, periarthritis (shoulder pain) and osteoarthritis (joint pains), stiffness.
As with all drugs, therapy appropriateness when using nimesulide is of outmost importance to safeguard patient’s health and guarantee the product’s therapeutic value.
NImesulide is available in the dosage of 100 mgs for tablets, 100 mg for granules for oral suspension, 200mg for suppositories and 3% of gel. And the prescribed duration to use is for 15 days. 
Continuous use of NImesulide may cause cetain side effects like Diarrhea, vomiting, skin rash e.t.c, It also preffered to use for the age above 12. Women should use the drug with caution during lactation and it is contraindicated during pregnancy.
It must be used under supervision by a doctor in accordance with the approved indications and in compliance with the recommendations